Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

REAL ASSET ACQUISITION CORP. (RAAQ)

  • Business News
  • June 14, 2026, 08:41 UTC
  • 6
  • 1 comments

IQM任命Vanguard董事、前Deloitte Digital全球負責人Barbara Venneman為董事會成員

Market reaction Comment Full text

REAL ASSET ACQUISITION CORP. (RAAQ)

  • Business News
  • June 14, 2026, 08:40 UTC
  • 4
  • 1 comments

IQM beruft Barbara Venneman, Vorstandsmitglied bei Vanguard und ehemalige Global Head von Deloitte Digital, in seinen Vorstand

Market reaction Comment Full text

REAL ASSET ACQUISITION CORP. (RAAQ)

  • Business News
  • June 14, 2026, 08:40 UTC
  • 4
  • 1 comments

IQM nomina Barbara Venneman, Direttore del CdA di Vanguard ed ex Responsabile globale di Deloitte Digital, al suo consiglio di amministrazione

Market reaction Comment Full text

SHAPIR ENGINEERING AND INDUSTRY LTD (SPEN)

  • Business News
  • June 14, 2026, 08:33 UTC
  • 3
  • 1 comments

Register of shareholders, changes and share capital status – exercise of non-tradeable warrants

Market reaction Comment Full text

ICL GROUP LTD (ICL)

  • Business News
  • June 14, 2026, 07:55 UTC
  • 6
  • 1 comments

Identifying Details of New Security-ICL B8-I

Market reaction Comment Full text

INROM CONSTRUCTION INDUSTRIES LTD (INRM)

  • Business News
  • June 14, 2026, 07:29 UTC
  • 3
  • 1 comments

Trustee report for BONDS Series 1 for the year 2025, Strauss Lazar

Market reaction Comment Full text

LEGEND BIOTECH CORP (LEGN)

  • Business News
  • June 14, 2026, 07:15 UTC
  • 6
  • 1 comments

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Market reaction Comment Full text

Eli Lilly and Company (LLY)

  • Business News
  • June 14, 2026, 07:15 UTC
  • 6
  • 1 comments

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL

Market reaction Comment Full text

BITMINE IMMERSION TECHNOLOGIES, INC. (BMNR)

  • Business News
  • June 14, 2026, 07:10 UTC
  • 6
  • 1 comments

Bitmine Immersion Technologies gibt erste Dividendenausschüttung und Notierung der Vorzugsaktien der Serie A an der NYSE bekannt

Market reaction Comment Full text

BITMINE IMMERSION TECHNOLOGIES, INC. (BMNR)

  • Business News
  • June 14, 2026, 07:06 UTC
  • 6
  • 1 comments

Bitmine Immersion Technologies annonce les premiers dividendes et la cotation au NYSE de ses actions privilégiées de série A

Market reaction Comment Full text
  • Previous
  • 2829
  • 2830
  • 2831
  • 2832
  • 2833
  • Next

Search

News categories

  • Technical Exchange News(14168)
  • Event(6229)
  • SEC News(361397)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222250)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin